what glp-1 has the least side effects Comparing Ozempic, Wegovy and Other Drugs Stopping GLP-1s: Weight Regain and

And that came from a recent trial that was published in the New England Journal of Medicine

Abstract Glucagon-like peptide-1 receptor agonists (GLP-1RAs) emerged as a promising class of drugs and have been shown to be effective as a key regulator in managing glucose metabolism-associated diseases such as type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), cardiovascular effects, nephrological complications, diabetes, non-alcoholic fatty liver (NAFLD), as well as to control obesity

Conducted by Prime Therapeutics and Magellan Rx Management (MRx), the review sifted through pharmacy and medical claims data for 3,364 people with insurance plans that cover the GLP-1 drugs

With headlines and social media amplifying new findings, counseling patients on GLP-1 therapies has become more complex